345 related articles for article (PubMed ID: 15217557)
41. Genes can come true.
Phillips H
New Sci; 2002 Nov; 176(2371):30-3. PubMed ID: 12731520
[No Abstract] [Full Text] [Related]
42. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
[TBL] [Abstract][Full Text] [Related]
43. Insertional mutagenesis and clonal dominance: biological and statistical considerations.
Fehse B; Roeder I
Gene Ther; 2008 Jan; 15(2):143-53. PubMed ID: 17972922
[TBL] [Abstract][Full Text] [Related]
44. A review of gene therapy for haematological disorders.
Nathwani AC; Davidoff AM; Linch DC
Br J Haematol; 2005 Jan; 128(1):3-17. PubMed ID: 15606545
[TBL] [Abstract][Full Text] [Related]
45. Regulators split on gene therapy as patient shows signs of cancer.
Check E
Nature; 2002 Oct; 419(6907):545-6. PubMed ID: 12374936
[No Abstract] [Full Text] [Related]
46. Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions.
Gammaitoni L; Lucchi S; Bruno S; Tesio M; Gunetti M; Pignochino Y; Migliardi G; Lazzari L; Aglietta M; Rebulla P; Piacibello W
Stem Cells; 2006 May; 24(5):1201-12. PubMed ID: 16410386
[TBL] [Abstract][Full Text] [Related]
47. Harmful potential of viral vectors fuels doubts over gene therapy.
Check E
Nature; 2003 Jun; 423(6940):573-4. PubMed ID: 12789298
[No Abstract] [Full Text] [Related]
48. Modeling human hematopoietic stem cell gene therapy in nonhuman primates.
Hematti P
Curr Hematol Rep; 2004 Jul; 3(4):282-9. PubMed ID: 15217558
[TBL] [Abstract][Full Text] [Related]
49. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells.
Zhang J; Attar E; Cohen K; Crumpacker C; Scadden D
Gene Ther; 2005 Oct; 12(19):1444-52. PubMed ID: 15877047
[TBL] [Abstract][Full Text] [Related]
50. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
51. Cellular gene therapy.
Lee JH; Klein HG
Hematol Oncol Clin North Am; 1995 Feb; 9(1):91-113. PubMed ID: 7737946
[TBL] [Abstract][Full Text] [Related]
52. Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?
Mikkers H; Pike-Overzet K; Staal FJ
Pediatr Res; 2012 Apr; 71(4 Pt 2):427-32. PubMed ID: 22430378
[TBL] [Abstract][Full Text] [Related]
53. Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions.
Giordano FA; Fehse B; Hotz-Wagenblatt A; Jonnakuty S; del Val C; Appelt JU; Nagy KZ; Kuehlcke K; Naundorf S; Zander AR; Zeller WJ; Ho AD; Fruehauf S; Laufs S
Bone Marrow Transplant; 2006 Aug; 38(3):229-35. PubMed ID: 16785865
[TBL] [Abstract][Full Text] [Related]
54. Retroviral transduction of IL-7Ralpha into IL-7Ralpha-/- bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia.
Jiang Q; Li WQ; Aiello FB; Klarmann KD; Keller JR; Durum SK
Gene Ther; 2005 Dec; 12(24):1761-8. PubMed ID: 16208423
[TBL] [Abstract][Full Text] [Related]
55. Gene therapy insertional mutagenesis insights.
Davé UP; Jenkins NA; Copeland NG
Science; 2004 Jan; 303(5656):333. PubMed ID: 14726584
[No Abstract] [Full Text] [Related]
56. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
57. Adenoviral vectors for transient gene expression in human primitive hematopoietic cells: applications and prospects.
Järås M; Brun AC; Karlsson S; Fan X
Exp Hematol; 2007 Mar; 35(3):343-9. PubMed ID: 17309814
[TBL] [Abstract][Full Text] [Related]
58. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
59. [Gene therapy in the treatment of colorectal cancer liver metastases].
Habib N; Jensen S
Bull Acad Natl Med; 2003; 187(5):893-7. PubMed ID: 14979054
[TBL] [Abstract][Full Text] [Related]
60. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
Kaiser J
Science; 2003 Jan; 299(5606):495. PubMed ID: 12543948
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
